Clinical Trials Directory

Trials / Suspended

SuspendedNCT01996358

Comparing Intubating Conditions Using Succinylcholine or Rocuronium for Rigid Bronchoscopy

Comparing Intubating Conditions Using Succinylcholine or Rocuronium/Sugammadex for Rigid Bronchoscopy: a Randomized Study

Status
Suspended
Phase
N/A
Study type
Interventional
Enrollment
150 (estimated)
Sponsor
Dr. Horst Schmidt Klinik GmbH · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Succinylcholine is commonly used for neuromuscular relaxation for short procedures such as rigid bronchoscopy. A more modern alternative is the application aof rocuronium, reversed by sugammadex. The investigators compare the intubating conditions, incidence of postoperative myalgia (POM) as well as patient satisfaction for these two muscle relaxants.

Conditions

Interventions

TypeNameDescription
DRUGSuccinylcholineAnaesthesia is induced and maintained with propofol (1-2 mg/kg) and remifentanil (0,5 µg/kg). The study arm is immobilized and after cleaning the skin a dual electrode for peripheral nerve stimulation is placed over the ulnar nerve near the wrist. Neuromuscular monitoring is performed with accelerometry. After induction of anaesthesia the patient receives muscle relaxant according to the study group.
DRUGRocuronium 0,3General anaesthesia is induced and maintained with propofol (1-2mg/kg) and remifentanil (0,5µg/kg). The study arm is immobilized and after cleaning the skin a dual electrode for peripheral nerve stimulation is placed over the ulnar nerve near the wrist. Neuromuscular monitoring is performed with accelerometry. The Patient receives the muscle relaxant according to the study group.
DRUGRocuronium 0,6General anaesthesia is induced and maintained with propofol (1-2mg/kg) and remifentanil (0,5µg/kg). The study arm is immobilized and after cleaning the skin a dual electrode for peripheral nerve stimulation is placed over the ulnar nerve near the wrist. Neuromuscular monitoring is performed with accelerometry. The Patient receives the muscle relaxant according to the study group.

Timeline

Start date
2015-08-01
Primary completion
2017-12-01
First posted
2013-11-27
Last updated
2017-04-04

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT01996358. Inclusion in this directory is not an endorsement.